A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions.

Sirivichayakul, Sunee; Kanchanatawan, Buranee; Thika, Supaksorn; Carvalho, André F; Maes, Michael

Sirivichayakul, Sunee; Kanchanatawan, Buranee; Thika, Supaksorn; Carvalho, André F; Maes, Michael.

Afiliação

Sirivichayakul S; Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Kanchanatawan B; Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Thika S; Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Carvalho AF; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Maes M; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.

CNS Neurol Disord Drug Targets ; 18(2): 124-140, 2019.

Article em En | MEDLINE | ID: mdl-30451122

Assuntos

Transtornos da Memória/tratamento farmacológico; Esquizofrenia/tratamento farmacológico; Triptofano/farmacologia; Xanturenatos/farmacologia; Ansiedade/tratamento farmacológico; Ansiedade/metabolismo; Transtornos de Ansiedade/tratamento farmacológico; Humanos; Transtornos da Memória/complicações; Testes Neuropsicológicos; Esquizofrenia/metabolismo

Palavras-chave

Deficit schizophrenia; cytokines; immune; inflammation; kynurenine; oxidative stress.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Triptofano / Xanturenatos / Transtornos da Memória Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Revista: CNS Neurol Disord Drug Targets Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google